Citing independent newspaper
TOP ARTICLES
A US retailer has said it will suspend sales of popular heartburn treatment Zantac at its pharmacies over a fears it could be linked to an increased risk of cancer.
CVS Health Corp said it will also discontinue its own-brand ranitidine products, which help reduce stomach acid, until further notice.
The US Food and Drug Administration (FDA) found traces of a known carcinogen in some medicines containing the drug ranitidine, including Zantac products, in findings published earlier this month.
Walgreens and Walmart have also stopped selling Zantac.
“This action is being taken out of an abundance of caution due to a recent Product Alert from the FDA,” a CVS Health statement said, “that ranitidine products may contain a low level of nitrosodimethylamine (NDMA), which is a probable human carcinogen.”
ليست هناك تعليقات:
إرسال تعليق